AAPL288.37+6.63 (+2.35%) ▲|ABBV251.95-2.37 (-0.93%) ▼|ABT91.04-1.68 (-1.81%) ▼|ACN123.78-0.96 (-0.77%) ▼|ADBE202.94-3.49 (-1.69%) ▼|AMAT734.71+40.07 (+5.77%) ▲|AMD579.42+39.93 (+7.40%) ▲|AMGN361.56+1.01 (+0.28%) ▲|AMT165.18-3.49 (-2.07%) ▼|AMZN238.75-1.39 (-0.58%) ▼|AVGO375.45+3.00 (+0.80%) ▲|AXP337.67-3.22 (-0.94%) ▼|BA216.21+1.52 (+0.71%) ▲|BAC57.25-0.64 (-1.10%) ▼|BKNG179.08-3.33 (-1.83%) ▼|BLK960.13+9.96 (+1.05%) ▲|BMY57.93-0.63 (-1.08%) ▼|BNY145.06+1.26 (+0.88%) ▲|BRK-B497.96+1.96 (+0.39%) ▲|C140.62-1.87 (-1.31%) ▼|CAT1,069.75+36.56 (+3.54%) ▲|CL91.86-0.54 (-0.58%) ▼|CMCSA24.37+0.15 (+0.60%) ▲|COF201.15-1.13 (-0.56%) ▼|COP104.12-0.08 (-0.08%) ▼|COST936.84-9.84 (-1.04%) ▼|CRM156.03-1.90 (-1.20%) ▼|CSCO117.28-0.42 (-0.36%) ▼|CVS103.93+0.35 (+0.34%) ▲|CVX167.01-1.46 (-0.87%) ▼|DE634.41+9.40 (+1.50%) ▲|DHR190.84-1.94 (-1.01%) ▼|DIS96.57-1.31 (-1.34%) ▼|DUK127.68-0.65 (-0.51%) ▼|EMR143.72+0.90 (+0.63%) ▲|FDX311.12-14.28 (-4.39%) ▼|GD352.88+4.81 (+1.38%) ▲|GE368.93-4.78 (-1.28%) ▼|GEV1,162.31+59.80 (+5.42%) ▲|GILD126.05-0.28 (-0.22%) ▼|GM76.57-0.78 (-1.00%) ▼|GOOG353.14+1.86 (+0.53%) ▲|GOOGL356.18+2.53 (+0.72%) ▲|GS1,013.39-6.83 (-0.67%) ▼|HD352.23+1.42 (+0.40%) ▲|HON224.07-3.73 (-1.64%) ▼|IBM280.39+2.39 (+0.86%) ▲|INTC141.86+10.14 (+7.70%) ▲|INTU261.90-4.51 (-1.69%) ▼|ISRG400.45-5.52 (-1.36%) ▼|JNJ256.31-2.20 (-0.85%) ▼|JPM328.81-0.58 (-0.18%) ▼|KO81.90-0.76 (-0.91%) ▼|LIN521.58+10.52 (+2.06%) ▲|LLY1,210.15-19.78 (-1.61%) ▼|LMT505.37+3.30 (+0.66%) ▲|LOW219.70+0.05 (+0.02%) ▲|LRCX434.39+23.48 (+5.71%) ▲|MA511.82+2.18 (+0.43%) ▲|MCD270.52+3.34 (+1.25%) ▲|MDLZ58.51-1.65 (-2.73%) ▼|MDT78.82-2.11 (-2.61%) ▼|META560.14-2.46 (-0.44%) ▼|MMM161.47-0.97 (-0.59%) ▼|MO72.75-1.30 (-1.75%) ▼|MRK128.34-1.04 (-0.80%) ▼|MS209.36-2.36 (-1.11%) ▼|MSFT371.16+2.59 (+0.70%) ▲|MU1,154.96+9.68 (+0.85%) ▲|NEE88.24-0.43 (-0.48%) ▼|NFLX72.44-1.35 (-1.82%) ▼|NKE41.53+0.05 (+0.12%) ▲|NOW97.50-2.47 (-2.47%) ▼|NVDA198.24+3.27 (+1.68%) ▲|ORCL146.39-1.38 (-0.93%) ▼|PEP136.73-1.95 (-1.41%) ▼|PFE24.14-0.23 (-0.94%) ▼|PG146.45-2.00 (-1.35%) ▼|PLTR117.94+2.24 (+1.94%) ▲|PM181.01-1.86 (-1.01%) ▼|QCOM185.97-2.75 (-1.46%) ▼|RTX187.92+0.59 (+0.32%) ▲|SBUX103.01-1.05 (-1.01%) ▼|SCHW92.35+1.80 (+1.99%) ▲|SO96.46-0.29 (-0.30%) ▼|SPG224.76-2.81 (-1.23%) ▼|T20.76-1.07 (-4.88%) ▼|TMO502.51-3.91 (-0.77%) ▼|TMUS168.35-5.62 (-3.23%) ▼|TSLA416.90+5.06 (+1.23%) ▲|TXN297.42+11.94 (+4.18%) ▲|UBER72.82-2.68 (-3.55%) ▼|UNH416.40-3.42 (-0.81%) ▼|UNP272.73+0.03 (+0.01%) ▲|UPS107.42-0.60 (-0.55%) ▼|USB60.73-0.03 (-0.05%) ▼|V342.83+1.18 (+0.35%) ▲|VZ42.62-1.49 (-3.37%) ▼|WFC82.82-0.69 (-0.83%) ▼|WMT113.55-1.05 (-0.92%) ▼|XOM136.31+0.25 (+0.18%) ▲|AAPL288.37+6.63 (+2.35%) ▲|ABBV251.95-2.37 (-0.93%) ▼|ABT91.04-1.68 (-1.81%) ▼|ACN123.78-0.96 (-0.77%) ▼|ADBE202.94-3.49 (-1.69%) ▼|AMAT734.71+40.07 (+5.77%) ▲|AMD579.42+39.93 (+7.40%) ▲|AMGN361.56+1.01 (+0.28%) ▲|AMT165.18-3.49 (-2.07%) ▼|AMZN238.75-1.39 (-0.58%) ▼|AVGO375.45+3.00 (+0.80%) ▲|AXP337.67-3.22 (-0.94%) ▼|BA216.21+1.52 (+0.71%) ▲|BAC57.25-0.64 (-1.10%) ▼|BKNG179.08-3.33 (-1.83%) ▼|BLK960.13+9.96 (+1.05%) ▲|BMY57.93-0.63 (-1.08%) ▼|BNY145.06+1.26 (+0.88%) ▲|BRK-B497.96+1.96 (+0.39%) ▲|C140.62-1.87 (-1.31%) ▼|CAT1,069.75+36.56 (+3.54%) ▲|CL91.86-0.54 (-0.58%) ▼|CMCSA24.37+0.15 (+0.60%) ▲|COF201.15-1.13 (-0.56%) ▼|COP104.12-0.08 (-0.08%) ▼|COST936.84-9.84 (-1.04%) ▼|CRM156.03-1.90 (-1.20%) ▼|CSCO117.28-0.42 (-0.36%) ▼|CVS103.93+0.35 (+0.34%) ▲|CVX167.01-1.46 (-0.87%) ▼|DE634.41+9.40 (+1.50%) ▲|DHR190.84-1.94 (-1.01%) ▼|DIS96.57-1.31 (-1.34%) ▼|DUK127.68-0.65 (-0.51%) ▼|EMR143.72+0.90 (+0.63%) ▲|FDX311.12-14.28 (-4.39%) ▼|GD352.88+4.81 (+1.38%) ▲|GE368.93-4.78 (-1.28%) ▼|GEV1,162.31+59.80 (+5.42%) ▲|GILD126.05-0.28 (-0.22%) ▼|GM76.57-0.78 (-1.00%) ▼|GOOG353.14+1.86 (+0.53%) ▲|GOOGL356.18+2.53 (+0.72%) ▲|GS1,013.39-6.83 (-0.67%) ▼|HD352.23+1.42 (+0.40%) ▲|HON224.07-3.73 (-1.64%) ▼|IBM280.39+2.39 (+0.86%) ▲|INTC141.86+10.14 (+7.70%) ▲|INTU261.90-4.51 (-1.69%) ▼|ISRG400.45-5.52 (-1.36%) ▼|JNJ256.31-2.20 (-0.85%) ▼|JPM328.81-0.58 (-0.18%) ▼|KO81.90-0.76 (-0.91%) ▼|LIN521.58+10.52 (+2.06%) ▲|LLY1,210.15-19.78 (-1.61%) ▼|LMT505.37+3.30 (+0.66%) ▲|LOW219.70+0.05 (+0.02%) ▲|LRCX434.39+23.48 (+5.71%) ▲|MA511.82+2.18 (+0.43%) ▲|MCD270.52+3.34 (+1.25%) ▲|MDLZ58.51-1.65 (-2.73%) ▼|MDT78.82-2.11 (-2.61%) ▼|META560.14-2.46 (-0.44%) ▼|MMM161.47-0.97 (-0.59%) ▼|MO72.75-1.30 (-1.75%) ▼|MRK128.34-1.04 (-0.80%) ▼|MS209.36-2.36 (-1.11%) ▼|MSFT371.16+2.59 (+0.70%) ▲|MU1,154.96+9.68 (+0.85%) ▲|NEE88.24-0.43 (-0.48%) ▼|NFLX72.44-1.35 (-1.82%) ▼|NKE41.53+0.05 (+0.12%) ▲|NOW97.50-2.47 (-2.47%) ▼|NVDA198.24+3.27 (+1.68%) ▲|ORCL146.39-1.38 (-0.93%) ▼|PEP136.73-1.95 (-1.41%) ▼|PFE24.14-0.23 (-0.94%) ▼|PG146.45-2.00 (-1.35%) ▼|PLTR117.94+2.24 (+1.94%) ▲|PM181.01-1.86 (-1.01%) ▼|QCOM185.97-2.75 (-1.46%) ▼|RTX187.92+0.59 (+0.32%) ▲|SBUX103.01-1.05 (-1.01%) ▼|SCHW92.35+1.80 (+1.99%) ▲|SO96.46-0.29 (-0.30%) ▼|SPG224.76-2.81 (-1.23%) ▼|T20.76-1.07 (-4.88%) ▼|TMO502.51-3.91 (-0.77%) ▼|TMUS168.35-5.62 (-3.23%) ▼|TSLA416.90+5.06 (+1.23%) ▲|TXN297.42+11.94 (+4.18%) ▲|UBER72.82-2.68 (-3.55%) ▼|UNH416.40-3.42 (-0.81%) ▼|UNP272.73+0.03 (+0.01%) ▲|UPS107.42-0.60 (-0.55%) ▼|USB60.73-0.03 (-0.05%) ▼|V342.83+1.18 (+0.35%) ▲|VZ42.62-1.49 (-3.37%) ▼|WFC82.82-0.69 (-0.83%) ▼|WMT113.55-1.05 (-0.92%) ▼|XOM136.31+0.25 (+0.18%) ▲|
32 C
New York
Tuesday, June 30, 2026

Tag: facility

T1 Energy Advances $850 Million Planned 5 GW Solar Cell Plant

T1 Energy announces significant progress towards $850 million, 5 GW solar cell facility.

ITM and ILL Extend Collaboration on the Manufacturing and Supply of Medical Lutetium-177 Radioisotope

Garching / Munich, Germany, and Grenoble, France, June 16, 2025 – ITM Isotope Technologies Munich SE (ITM) and the Institut Laue-Langevin (ILL), today announced an extension of their collaboration for medical radioisotope production, originally established in 2009. Under the terms of the renewed agreement, ITM will receive priority access to half of the available neutron irradiation capacity at ILL’s High-Flux Reactor, its neutron irradiation facility, for the production of non-carrier-added Lutetium-177 (n.c.a. Lu-177), a critical medical radioisotope used for radiopharmaceutical therapies for cancer treatment and diagnosis. As the globally leading manufacturer of n.c.a. Lu-177, ITM is committed to maintaining and expanding its robust manufacturing and production capabilities to meet the growing demand for this vital medical radioisotope.

China Clean Expo 2026: Leveraging China’s Booming Cleaning Market for Global Opportunities

SHANGHAI, June 16, 2025 /PRNewswire/ -- The 27th China Clean Expo (CCE), organized by IM Sinoexpo and supported by ISSA – The Worldwide Cleaning...

RayStation used for pioneering clinical milestone at Helsinki University Hospital – first treatment with accelerator-based BNCT in Europe

STOCKHOLM, June 16, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is pleased to announce that RayStation®*, its advanced treatment planning system, was used in...

NX Malaysia Opens New Batu Kawan Logistics Center near Penang’s Batu Kawan Industrial Park

-Nearly 10,000m2 of Warehouse Space Available for Semiconductor, Medical Equipment and Other Companies- TOKYO, June 16, 2025 /PRNewswire/ -- Nippon Express (Malaysia) Sdn, Bhd. (hereafter...

STL expands Data Centre portfolio to meet emerging requirements for AI data centres

- High-performance, comprehensive cabling and connectivity solutions and engineering services - Fully compliant solutions, meeting international standards MUMBAI, India, June 16, 2025 /PRNewswire/ -- STL (NSE:...

SDP Japan Raises $31 Million in Series D Round

Pioneering the Future of Surgical Care in Response to Rising DemandTOKYO, June 15, 2025 /PRNewswire/ -- SDP Japan, Inc. (Shibuya-ku, Tokyo; CEO: Kazuhiko Nagayo),...

Jack L. Marcus, Inc. Issues Notice of Privacy Breach Affecting Wisconsin Department of Corrections Population

MILWAUKEE, June 15, 2025 (GLOBE NEWSWIRE) -- Jack L. Marcus, Inc. is providing notice of a privacy breach involving the protected health information (PHI) of individuals in the care of the Wisconsin Department of Corrections (DOC). The breach involved the unintentional disclosure of the names of six DOC treatment facilities through Jack L. Marcus’s public ordering website.

Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025

HAMPTON, N.J., June 14, 2025 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced data demonstrating that barzolvolimab profoundly improves angioedema at 52 weeks in the Company’s Phase 2 clinical trial in chronic spontaneous urticaria (CSU). Angioedema, characterized by swelling of the deeper dermal layers of the skin and mucous membranes, is a painful, debilitating symptom of CSU that has significant impact on quality of life. It commonly affects the face (lips and eyelids), hands, feet, and genitalia but can also involve the tongue, uvula, soft palate, and pharynx1.

Aslan Energy Capital and JIEP Sign Heads of Agreement to Develop East Jakarta’s Renewable-Powered Hyperscale Data Center

JAKARTA, Indonesia, June 14, 2025 /PRNewswire/ -- Aslan Energy Capital (AEC), a Singapore-based developer of clean energy infrastructure, has signed a binding Heads of...

Guardians of the Ocean: SUS ENVIRONMENT’s Pioneering Waste-to-Energy Plant by the Sea

SHANGHAI, June 14, 2025 /PRNewswire/ -- Nestled along Sanmen Bay in the heart of China's "Golden Coastline," a waste-to-energy plant stands as a beacon of...

Millicom (Tigo) Strengthens South American Leadership with USD 380 Million Acquisition of Telefónica Ecuador

Millicom (Tigo) Strengthens South American Leadership with USD 380 Million Acquisition of Telefónica Ecuador

ROSEN, A LEADING LAW FIRM, Encourages Red Cat Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RCAT

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Red Cat Holdings, Inc. (NASDAQ: RCAT) between March 18, 2022 and January 15, 2025, both dates inclusive (the “Class Period”), of the important July 22, 2025 lead plaintiff deadline.

MacKenzie Realty Capital Secures $3 Million Loan for Non-Traded REIT Shares

ORINDA, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- MacKenzie Realty Capital, Inc. (Nasdaq: MKZR) (“MacKenzie” or the “Company”) today announced the closing of a $3 million loan agreement with an institutional investor for the purchase of non-traded REIT shares.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsFacility